Iron in Restless Legs Syndrome

Area of Science:

• Neurology
• Metabolic Disorders
• Genetics

Background:

• A long-recognized association exists between restless legs syndrome (RLS) and iron.
• The exact mechanisms by which iron metabolism influences RLS pathophysiology remain incompletely understood.
• Recent advancements in genetics, pathology, imaging, and clinical research offer new insights.

Purpose of the Study:

• To systematically review and critically analyze the current literature on the role of iron in RLS.
• To elucidate the complex interplay between iron metabolism and RLS.
• To highlight areas requiring further investigation in RLS research.

Main Methods:

• Systematic literature review of studies on iron in RLS.
• Critical analysis of evidence from genetics, neuropathology, and cell/animal models.
• Evaluation of imaging studies and therapeutic interventions related to iron in RLS.

Main Results:

• Iron deficiency is a key factor in RLS, particularly affecting dopaminergic neurotransmission.
• Genetic factors influencing iron regulation are implicated in RLS susceptibility.
• Imaging studies reveal altered brain iron deposition in RLS patients.
• Iron supplementation shows therapeutic benefits for many RLS patients.

Conclusions:

• Iron metabolism plays a crucial role in the pathophysiology of restless legs syndrome.
• Further research is needed to fully understand the genetic and molecular mechanisms linking iron to RLS.
• Optimizing iron status is an important therapeutic strategy for managing RLS symptoms.